1JACOBS F M,VAN DER L P,HEIDE P J,et al.FoxO6 a novel member of the FoxO class of transcription factors with distinct shuttling dynamics[J].J Biol Chem,2003,278:35959-35967.
2OBSIL T,OBSILOVA V.Structure/function relationships underlying regulation of FOXO transcription factors[J].Oncogene,2008,27:2263-2275.
3ZHAO X,GAN L,PAN H,et al.Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1:characterization of phosphorylation and 14-3-3dependent and independent mechanisms[J].Biochem J,2004,37:8839-8849.
4MATSUZAKI H,DAITOKU H,HATTA M,et al.Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation[J].Proc Natl Acad Sci U S A,2005,102:11278-11283.
5PLAS D R,THOMPSON C B.Akt activation promotes degradation of tuberin and FOXO3a via the proteasome[J].J Biol Chem,2003,278:12361-12366.
6MATSUZAKI H,DAITOKU H,HATTA M,et al.Insulininduced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation[J].Proc Natl Acad Sci U S A,2003,100:11285-11290.
7HU M C,LEE D F,XIA W,et al.IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a[J].Cell,2004,117:225-237.
8PAIK J H,KOLLIPARA R,CHU G,et al.FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis[J].Cell,2007,128:309-323.
9SAMUELS Y,DIAZ JR L A,et al.Mutant PIK3CA promotes cell growth and invasion of human cancer cells[J].Cancer Cell,2005,7:561-573.
10LI P,LEE H,GUO S,et al.AKTindependent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR[J].Mol Cell Biol,2003,23:104-118.
3MAYER R J, DAVIS R B, SCHIFFER C A, et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and leukemia group B [J]. N Engl J Med ,1994, 331:896-903.
4BRUSERUD O, TJONNFJORD G, GJERTSEN B T, et al. New strategies in treatment of acute myelogenous leukemia : mobilization and transplantation of autologous peripheral blood stem cells in adult patients[J]. Stem cells, 2000, 18(5) :343-351.
5KIM S T, JUNG C W, LEE J, et al. Postremission therapy for acute myeloid leukemia in first remission [J]. Leuk Lymphoma, 2007,48: 937-943.
6MICHALLET A S, CHELGHOUM Y, THIEBAUT A, et al. Autologous hematopoietic stem cell transplantation for adults with acute myeloid leukemia in complete remission: the Edouard Herriot Hospital experience[J]. Hematology, 2006, 11(3) : 157-164.
7Kenneth J,Livak ,Thomas D,et al. Analysis of relative Gene expression data using real-time quantitative PCR and the 2^-△△CT method [J]. Methods,2001,25 (4):402- 408
8Sattler M, Mohi MG, Pride YB, et al. Critical role of Gab2 in transformation by BCR/ABL [ J ]. Cancer Cell, 2002, 1 (5) : 479-492
9Skorski T,Kanakaraj P, Nieborowska-Skorska M,et al. Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells [ J ]. Blood, 1995,86 (2) : 726 - 736
10Klajman A, Schreiner SJ,Nieborowska-Skorska M,et al. The Src family kinase Hck couples BCR/ABL to STATS activation in myeloid leukemia cells [J]. EMBO J, 2002,21 (21 ) : 5766-5774
